UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 78

Sortiert nach

Evaluation of Ranolazine in Patients With Type 2 Diabetes Mellitus and Chronic Stable Angina

Journal of the American College of Cardiology, 2013-05, Vol.61 (20), p.2038-2045

2013

Volltextzugriff (PDF)

Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial

JACC. Cardiovascular imaging, 2009-08, Vol.2 (8), p.959-968

2009

Volltextzugriff (PDF)

Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans

Journal of nuclear cardiology, 2007-07, Vol.14 (4), p.514-520

2007

Volltextzugriff (PDF)

Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: Design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post–Percutaneous Coronary Intervention (RIVER-PCI) trial

The American heart journal, 2013-12, Vol.166 (6), p.953-959.e3

2013

Volltextzugriff (PDF)

Effectiveness of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina according to baseline hemoglobin A1c

The American heart journal, 2014-10, Vol.168 (4), p.457-465.e2

2014

Volltextzugriff (PDF)

Interaction of Caffeine With Regadenoson-Induced Hyperemic Myocardial Blood Flow as Measured by Positron Emission Tomography

Journal of the American College of Cardiology, 2008, Vol.51 (3), p.328-329

2008

Volltextzugriff (PDF)

The HARMONY Trial: Combined Ranolazine and Dronedarone in the Management of Paroxysmal Atrial Fibrillation: Mechanistic and Therapeutic Synergism

Circulation. Arrhythmia and electrophysiology, 2015-10, Vol.8 (5), p.1048-1056

2015

Volltextzugriff (PDF)

Evaluation of Ranolazine in Patients With Type 2 Diabetes Mellitus and Chronic Stable Angina: Results From the TERISA Randomized Clinical Trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina)

Journal of the American College of Cardiology, 2013-05, Vol.61 (20), p.2038-2045

2013

Volltextzugriff (PDF)

P041 THE GUT-SELECTIVE, ORALLY ADMINISTERED, PAN-JAK INHIBITOR TD-1473 DEMONSTRATES FAVORABLE SAFETY, TOLERABILITY, PHARMACOKINETIC, AND SIGNAL FOR CLINICAL ACTIVITY IN SUBJECTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS

Gastroenterology (New York, N.Y. 1943), 2019-02, Vol.156 (3), p.S29-S30

2019

Volltextzugriff (PDF)

P041 THE GUT-SELECTIVE, ORALLY ADMINISTERED, PAN-JAK INHIBITOR TD-1473 DEMONSTRATES FAVORABLE SAFETY, TOLERABILITY, PHARMACOKINETIC, AND SIGNAL FOR CLINICAL ACTIVITY IN SUBJECTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS

Inflammatory bowel diseases, 2019-02, Vol.25 (Supplement_1), p.S20-S21

2019

Volltextzugriff (PDF)

Regadenoson Induces Comparable Left Ventricular Perfusion Defects as Adenosine

JACC. Cardiovascular imaging, 2009-08, Vol.2 (8), p.959-968

2009

Volltextzugriff (PDF)

Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trial

Journal of nuclear cardiology, 2007-09, Vol.14 (5), p.645-658

2007

Volltextzugriff (PDF)

Probability Models and the Applicability of Statistical Procedures in the Identification of Chromosomal Fragile Sites

Biometrics, 2002-12, Vol.58 (4), p.1028-1031

2002

Volltextzugriff (PDF)

Interaction of Caffeine With Regadenoson-Induced Hyperemic Myocardial Blood Flow as Measured by Positron Emission Tomography: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial

Journal of the American College of Cardiology, 2008-01, Vol.51 (3), p.328-329

2008

Volltextzugriff (PDF)

Abstract 188: Comparison of Physician- and Patient-Assessed Impressions of Treatment Efficacy: Insights from the TERISA Clinical Trial

Circulation Cardiovascular quality and outcomes, 2014-07, Vol.7 (suppl_1)

2014

Volltextzugriff (PDF)

Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans

Journal of nuclear cardiology, 2007-07, Vol.14 (4), p.514-520

2007

Volltextzugriff (PDF)

Effect of body mass index on the efficacy, side effect profile, and plasma concentration of fixed-dose regadenoson for myocardial perfusion imaging

Journal of nuclear cardiology, 2011-08, Vol.18 (4), p.620-627

2011

Volltextzugriff (PDF)

Abstract 6131: Regadenoson Induces Perfusion Defects of Comparable Extent and Severity as Adenosine: A Quantitative Analysis from the ADVANCE 2 Trial

Circulation (New York, N.Y.), 2008-10, Vol.118 (suppl_18)

2008

Volltextzugriff (PDF)

Regadenoson, a selective A 2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans

Journal of nuclear cardiology, 2007, Vol.14 (4), p.514-520

2007

Volltextzugriff (PDF)

Algorithms using chi-squared and other goodness of fit tests to identify a high-expectation subset of independent Poisson random variables, or a subset of multinomial cells having relatively high probabilities, with applications in chromosomal fragile site identification

Olmsted, Ann Walls

1999

Volltextzugriff (PDF)

Stances Teachers Take: A Basis for Selective Admission

Phi Delta Kappan, 1974-01, Vol.55 (5), p.330-334

1974

Volltextzugriff (PDF)

Electronic media: Management and litigation issues when "delete" doesn't mean delete

Defense counsel journal, 1996-10, Vol.63 (4), p.523

Olmsted, Betty Ann

1996

Volltextzugriff (PDF)

Reviews -- Health Care and Cultural Change: The Indian Experience in the Central Subarctic by T. Kue Young

Contemporary Sociology, 1990, Vol.19 (2), p.293

Olmsted, Ann

1990

Volltextzugriff (PDF)

T. Kue Young: "Health Care and Cultural Change: The Indian Experience in the Central Subarctic" (Book Review)

Contemporary Sociology, 1990, Vol.19 (2), p.293

Olmsted, Ann

1990

Volltextzugriff (PDF)

Minutes, Meeting of Council: The Ohio Valley Sociological Society, Statler Hilton Hotel, Detroit, Michigan, Thursday, May 2, 1968

Sociological focus (Kent, Ohio), 1968-10, Vol.2 (1), p.61-66

Olmsted, Ann G.

1968

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(68)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(78)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evaluation of Ranolazine in Patients With Type 2 Diabetes Mellitus and Chronic Stable Angina

Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trial

Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans

Use of ranolazine in patients with incomplete revascularization after percutaneous coronary intervention: Design and rationale of the Ranolazine for Incomplete Vessel Revascularization Post–Percutaneous Coronary Intervention (RIVER-PCI) trial

Effectiveness of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina according to baseline hemoglobin A1c

Interaction of Caffeine With Regadenoson-Induced Hyperemic Myocardial Blood Flow as Measured by Positron Emission Tomography

The HARMONY Trial: Combined Ranolazine and Dronedarone in the Management of Paroxysmal Atrial Fibrillation: Mechanistic and Therapeutic Synergism

Evaluation of Ranolazine in Patients With Type 2 Diabetes Mellitus and Chronic Stable Angina: Results From the TERISA Randomized Clinical Trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina)

P041 THE GUT-SELECTIVE, ORALLY ADMINISTERED, PAN-JAK INHIBITOR TD-1473 DEMONSTRATES FAVORABLE SAFETY, TOLERABILITY, PHARMACOKINETIC, AND SIGNAL FOR CLINICAL ACTIVITY IN SUBJECTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS

P041 THE GUT-SELECTIVE, ORALLY ADMINISTERED, PAN-JAK INHIBITOR TD-1473 DEMONSTRATES FAVORABLE SAFETY, TOLERABILITY, PHARMACOKINETIC, AND SIGNAL FOR CLINICAL ACTIVITY IN SUBJECTS WITH MODERATELY-TO-SEVERELY ACTIVE ULCERATIVE COLITIS

Regadenoson Induces Comparable Left Ventricular Perfusion Defects as Adenosine

Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: Results of the ADVANCE phase 3 multicenter international trial

Probability Models and the Applicability of Statistical Procedures in the Identification of Chromosomal Fragile Sites

Interaction of Caffeine With Regadenoson-Induced Hyperemic Myocardial Blood Flow as Measured by Positron Emission Tomography: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial

Abstract 188: Comparison of Physician- and Patient-Assessed Impressions of Treatment Efficacy: Insights from the TERISA Clinical Trial

Regadenoson, a selective A2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans

Effect of body mass index on the efficacy, side effect profile, and plasma concentration of fixed-dose regadenoson for myocardial perfusion imaging

Abstract 6131: Regadenoson Induces Perfusion Defects of Comparable Extent and Severity as Adenosine: A Quantitative Analysis from the ADVANCE 2 Trial

Regadenoson, a selective A 2A adenosine receptor agonist, causes dose-dependent increases in coronary blood flow velocity in humans

Algorithms using chi-squared and other goodness of fit tests to identify a high-expectation subset of independent Poisson random variables, or a subset of multinomial cells having relatively high probabilities, with applications in chromosomal fragile site identification

Stances Teachers Take: A Basis for Selective Admission

Electronic media: Management and litigation issues when "delete" doesn't mean delete

Reviews -- Health Care and Cultural Change: The Indian Experience in the Central Subarctic by T. Kue Young

T. Kue Young: "Health Care and Cultural Change: The Indian Experience in the Central Subarctic" (Book Review)

Minutes, Meeting of Council: The Ohio Valley Sociological Society, Statler Hilton Hotel, Detroit, Michigan, Thursday, May 2, 1968

Suchergebnisse filtern